CWM
IBB icon

Connecticut Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Connecticut Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Sell
2,405
-512
-18% -$88K 0.02% 248
2026
Q1 		$492K Buy
2,917
+514
+21% +$87.9K 0.02% 230
2025
Q4 		$406K Buy
2,403
+1
+0% +$162 0.02% 239
2025
Q3 		$347K Sell
2,402
-6,257
-72% -$854K 0.02% 259
2025
Q2 		$1.1M Hold
8,659
– – 0.05% 145
2025
Q1 		$1.11M Sell
8,659
-17
-0.2% -$2.31K 0.06% 141
2024
Q4 		$1.15M Sell
8,676
-20
-0.2% -$2.81K 0.06% 120
2024
Q3 		$1.27M Hold
8,696
– – 0.06% 136
2024
Q2 		$1.19M Sell
8,696
-319
-4% -$42.6K 0.06% 134
2024
Q1 		$1.24M Buy
9,015
+590
+7% +$80.6K 0.07% 126
2023
Q4 		$1.14M Sell
8,425
-748
-8% -$91.3K 0.07% 131
2023
Q3 		$1.12M Buy
9,173
+723
+9% +$91.9K 0.08% 108
2023
Q2 		$1.07M Sell
8,450
-157
-2% -$20.4K 0.07% 94
2023
Q1 		$1.11M Buy
8,607
+203
+2% +$26.6K 0.08% 87
2022
Q4 		$1.1M Hold
8,404
– – 0.09% 79
2022
Q3 		$983K Buy
8,404
+1
+0% +$124 0.09% 80
2022
Q2 		$988K Hold
8,403
– – 0.09% 87
2022
Q1 		$1.09M Buy
+8,403
New +$1.09M 0.08% 84
2020
Q2 		– Sell
-2,355
Closed -$254K – 141
2020
Q1 		$254K Hold
2,355
– – 0.04% 126
2019
Q4 		$284K Sell
2,355
-96
-4% -$10.7K 0.03% 139
2019
Q3 		$244K Buy
+2,451
New +$257K 0.03% 138

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Connecticut Wealth Management's IBB Position: Q2 2026 in Review

Connecticut Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q2 2026, selling an estimated $88K and leaving 2,405 shares worth $457K. The position accounts for 0.02% of the portfolio, ranked #248.

Connecticut Wealth Management first reported a position in IBB in Q3 2019 and has held it in 21 quarters since. The position peaked at $1.27M in Q3 2024. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Connecticut Wealth Management held 2,405 shares of iShares Biotechnology ETF worth $457K as of Q2 2026.
  • Connecticut Wealth Management sold 512 iShares Biotechnology ETF shares in Q2 2026, an estimated $88K.
  • iShares Biotechnology ETF made up 0.02% of Connecticut Wealth Management's portfolio in Q2 2026, its #248 holding.
  • Connecticut Wealth Management first reported a position in iShares Biotechnology ETF in Q3 2019 and has held it in 21 quarters since.
  • Connecticut Wealth Management's iShares Biotechnology ETF position peaked at $1.27M in Q3 2024.
  • 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.